Clinical Trials Logo

Clinical Trial Summary

Somatosensory evoked potentials corresponds to a neurophysiological exam that studies the functioning of the sensitivity pathways. It is often complementary to the imaging examination (MRI or scanner) and the electroneuromyogram which studies only the peripheral part of the sensory and motor pathways while the somatosensory evoked potentials are interested in their central and peripheral component. The studied information are the potentials generated in the nervous system by the presentation of sensory stimulation. The examination makes it possible to study conduction times which will be defined as normal or pathological according to standards established on control subjects. Their indication is multiple: study of the repercussions of cervical osteoarthritis, specify the diagnosis of certain neuropathies, study of the conduction pathways at the medullary level in the event of trauma or inflammatory or other lesion. In our study, the investigators will only be interested in the somatosensory evoked Potentials. A study has shown that hypnotic suggestions to reduce the unpleasantness of pain triggered by thermal stimulation lead to a selective reduction of activity in the anterior cingulate cortex without modifying the activation of the somesthetic cortex. Pain is, like all sensory stimulation, subject to the influences of attention, anticipation, mental imagery, previous conditioning. The fronto-cingular areas, activated by analgesics such as morphine, or by cortical stimulation are the same as those used by non-drug techniques such as hypnosis. Therapeutic hypnosis is "a relational experience bringing into play physiological and psychological mechanisms allowing the individual to live better, reduce or eliminate an acute or chronic painful pathology" (Definition of Doctor Jean Marc Benhaiem). The study of somatosensory evoked Potentials is a long examination (90 to 120 minutes), which can be uncomfortable for the patient (patient lying down, immobile and relaxed), not having to contract his muscles, especially if he is already painful due to his pathology or if it is difficult for him to remain motionless in the supine position. It is indeed necessary to average around 600 to 1000 responses (number of averages) to a small electrical simulation on each member studied. The muscular contractions of an anxious and/or painful patient prolong the duration of the examination or even disturb the results, to the point of making it impossible to interpret the examination. To our knowledge, hypnosis has already been used to improve muscle relaxation and reduce anxiety and pain during electromyograms, but hypnosis has never been used to improve the outcome of somatosensory evoked Potentials. Furthermore, if hypnosis modifies certain late cortical waves, it does not cause modification of the early waves and therefore does not disturb the results expected in our clinical practice.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04218448
Study type Interventional
Source Groupe Hospitalier Paris Saint Joseph
Contact
Status Terminated
Phase N/A
Start date January 13, 2020
Completion date April 6, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04699734 - Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy N/A
Completed NCT04054804 - Digital Foot Check by Using the D-Foot, a New Software
Completed NCT05161364 - Kinetic Analysis Due to Foot Dysfunction
Not yet recruiting NCT03899298 - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions Phase 1
Completed NCT02970006 - Investigating Mechanisms Underlying Spinal Cord Stimulation Efficacy Using Virtual Reality and Full Body Illusion N/A
Recruiting NCT05291286 - BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients Early Phase 1
Recruiting NCT04403802 - Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy N/A
Enrolling by invitation NCT05590117 - Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer Early Phase 1
Recruiting NCT05624138 - The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy Phase 3
Recruiting NCT06121232 - Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study N/A
Recruiting NCT05065554 - ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy Phase 2
Recruiting NCT05980767 - Short Duration Electrical Stimulation to Improve Outcomes After Cubital Tunnel Release (SELECT) Trial N/A
Completed NCT03135535 - Micro-mobile Foot Compression and Diabetic Foot Phase 2
Recruiting NCT03037684 - Depolarising Electrical Skin Stimulation in Neuropathic and Postoperative Pain
Recruiting NCT04865185 - Effect of Topical Lidocaine on Warm and Cold Sensation in Healthy Individuals N/A
Completed NCT05093023 - ABCB1 SNPs as Predictors of PIPN
Completed NCT05410548 - Comorbidity Screening and Referral by Prosthetists N/A
Completed NCT03021174 - Exercise and Nutrition Interventions During Chemotherapy N/A
Not yet recruiting NCT06422949 - Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy N/A
Terminated NCT03777956 - The Effect of Lacosamide in Peripheral Neuropathic Pain Phase 2